21 employees
We read your immune system to intercept diseases.
2021
$1.6M
from 2 investors over 2 rounds
OmniScope raised $1.6M on May 20, 2022
Investors: European Commission
OmniScope raised $1.2M on June 12, 2021
Investors: Malta Enterprise